PressReleasePoint - Biotechnology

French's New Stem Cell Research Projects Make Opportunities for U.S. Companies (Z146)

ftpo — Thu, 19 Nov 2009 15:53:03 -0500

FRENCH BIOTECH HOTBEDS GIVE RISE TO UNPRECEDENTED R&D COLLABORATION IN STEM CELL ENGINEERING
Partnership highlights unique R&D opportunities in France for U.S. Companies

Chicago, November 19, 2009 (word count: 397)

Cytokinetics Announces Non-Clinical Data Relating to GSK-923295 Presented at the 2009 AACR-NCI-EORTC International Conference

Cytokinetics — Thu, 19 Nov 2009 13:54:29 -0500

Data Support Hypothesis that GSK-923295 May be Active in Combination with Other Chemotherapeutics in the Clinical Setting

South San Francisco, CA - November 19, 2009

read more

Randox unveils cardiac care technology at major European medical event

Randox — Thu, 19 Nov 2009 07:50:27 -0500

RANDOX Laboratories (“Randox”), the Antrim-based independent global diagnostics company, will today unveil a revolutionary new cardiac machine at the world’s largest medical trade fair being held this week in Dusseldorf, Germany.

Bionic penguins among 50 top innovations of 2009

Craigie — Thu, 19 Nov 2009 06:30:20 -0500

November 19th, 2009 - Time magazine has named the bionic penguins developed at EvoLogics in cooperation with Festo as one of the top 50 innovations of the year. This developments are based on 25 years research into the biology of penguins, combined with EvoLogics' expertise in bionics and robotics.

National Microscope Exchange offers the newly released Atago PEN-Urine S. G. urine specific gravity refractometer to check for p

microscope — Thu, 19 Nov 2009 06:11:55 -0500

The newly released Atago PEN-Urine S.G. digital urine specific gravity refractometer, supplied by National Microscope Exchange, was developed to meet the needs for hydration testing by hospitals, clinics, athletic associations, probation offices and drug testing facilities.

National Microscope Exchange is now selling newly released products in Atago’s line of Master Series brix refractometers for tes

microscope — Thu, 19 Nov 2009 05:50:52 -0500

Atago Company has added new products to their Master series of brix refractometers, a line of hand held refractometers that is the next generation in brix testing. The Master series refractometers, as supplied by National Microscope Exchange, are perfect for testing fruit juices, soft drinks, and water soluble cutting oil.

M-Scan – 30 years of Innovations and beyond

m-scan@m-scan.com — Thu, 19 Nov 2009 04:47:36 -0500

From its inception in 1979, M-Scan have always been a forward thinking company. Its founder, Professor Howard Morris (FRS), saw the potential for the application of Fast Atom Bombardment Mass Spectrometry (FAB-MS) in the emerging biopharmaceutical industry and since then they have gone from strength to strength.

Fenwick & West Represents Underwriters in SolarWinds' Secondary Offering

Fenwick and West — Wed, 18 Nov 2009 22:14:10 -0500

11/18/2009

Oncolytics Biotech® Inc. Announces Terms of Unit Offering

Oncolytics — Wed, 18 Nov 2009 20:02:58 -0500

Genzyme Announces Results of Phase 2/3 Trial of Advanced Phosphate Binder

Genzyme — Wed, 18 Nov 2009 19:24:21 -0500

Date: November 18, 2009

Genentech and Biogen Idec Receive a Complete Response from the FDA for Rituxan for Chronic Lymphocytic Leukemia

Genentech — Wed, 18 Nov 2009 19:11:21 -0500

Genentech, Inc., a wholly-owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), and Biogen Idec (Nasdaq: BIIB) announced today that the U.S.

Oncolytics Biotech® Inc. Collaborators to Present Updated Phase I/II Trial Results in Advanced Solid Cancers with a Focus on the

Oncolytics — Wed, 18 Nov 2009 16:16:55 -0500

Genentech Announces Vice President Appointment in Research

Genentech — Wed, 18 Nov 2009 15:24:58 -0500

Genentech, Inc. (NYSE: DNA) today announced the appointment of Jennifer A. Doudna, Ph.D., to Vice President, Discovery Research. In this newly created position, Doudna will oversee the departments of protein chemistry and structural biology. She will be a member of the small molecule drug discovery senior leadership team and will participate in therapeutic RNA discovery efforts.

Oncolytics Biotech® Inc. Announces Unit Offering

Oncolytics — Wed, 18 Nov 2009 15:12:28 -0500

Genentech Submits Supplemental Applications to FDA for Avastin Combined with Commonly Used Chemotherapies for Women with Advance

Genentech — Wed, 18 Nov 2009 15:10:32 -0500

Genentech, Inc., a wholly-owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the company submitted two supplemental Biologics License Applications (sBLAs) to the U.S.